DAPT (GSI-IX); GSI-IX; gamma-Secretase Inhibitor IX; CHEMBL255682; MFCD04974585; N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine tert-butyl ester; N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-Butyl Ester; GSIIX; PubChem22436; DAPT,GSI-IX; DAPT;; LY-374973; DAPT - GSI-IX; N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester; InSolution gamma-Secretase Inhibitor IX; MLS006010075; QCR-29; SCHEMBL1360313; TB2634-GMP; KS-00000SRB; DTXSID00415519; EX-A324; C23H26F2N2O4; HMS3413L17; HMS3677L17; HMS3884P09; AOB33372; EBD16444; ZINC1549363; ABP000317; BDBM50478375; s2215; AKOS024457209; CCG-264944; CS-0264; SB19494; MRF-0000012; NCGC00167803-03; (3,5-Difluorophenylacetyl)-Ala-Phg-OtBu; AC-23163; AN-37124; AS-19399; HY-13027; SC-94298; SMR004701228; AB0033805; D4257; SW219339-1; X7572; W-5319; AB01566837_01; J-013656; J-524356; Q27158972; (3,5-Difluorophenylacetyl)-L-alanyl-L-2-phenylglycine tert-Butyl Ester; N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenylglycine tert-butyl ester; N-[N-(3,5-difluorophenylacetyl)-L-alanyl]-(S)-phenylglycine t-butyl ester; N-[2-(3,5-Difluorophenyl)acetyl]-L-alanyl-L-(2-phenyl)glycine tert-butyl ester; N-[N-(3,5-difluorophenacetyl)-L-alanyl]-(S)-phenylglycine tert-butyl ester;; N-[N-(3,5-difluorophenylacetyl)-L-alanyl]-(S)-phenylglycine t-butyl ester;; N-[N-(3,5-difluorophenylacetyl)-L-alanyl]-(S)-phenylglycine tert-butyl ester;; N-[N-(3,5-difluorophenylacetyl)-L-alanyl]-L-phenylglycine tert-butyl ester;; tert-butyl (2S)-({N-[(3,5-difluorophenyl)acetyl]-L-alanyl}amino)(phenyl)acetate